Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Payables (2016 - 2025)

Historic Payables for Iridex (IRIX) over the last 15 years, with Q3 2025 value amounting to $4.4 million.

  • Iridex's Payables fell 4133.07% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 4133.07%. This contributed to the annual value of $8.7 million for FY2024, which is 9379.86% up from last year.
  • As of Q3 2025, Iridex's Payables stood at $4.4 million, which was down 4133.07% from $5.3 million recorded in Q2 2025.
  • Iridex's 5-year Payables high stood at $8.7 million for Q4 2024, and its period low was $1.1 million during Q1 2021.
  • Moreover, its 5-year median value for Payables was $4.0 million (2022), whereas its average is $4.4 million.
  • Over the last 5 years, Iridex's Payables had its largest YoY gain of 30377.02% in 2021, and its largest YoY loss of 5570.99% in 2021.
  • Quarter analysis of 5 years shows Iridex's Payables stood at $3.2 million in 2021, then rose by 20.26% to $3.9 million in 2022, then grew by 16.61% to $4.5 million in 2023, then soared by 93.8% to $8.7 million in 2024, then tumbled by 49.43% to $4.4 million in 2025.
  • Its Payables was $4.4 million in Q3 2025, compared to $5.3 million in Q2 2025 and $6.0 million in Q1 2025.